-
公开(公告)号:US11155566B2
公开(公告)日:2021-10-26
申请号:US16771787
申请日:2018-12-04
申请人: UCB Biopharma SRL
发明人: Laurent Provins , Hugues Chanteux
IPC分类号: C07D513/04
摘要: The present invention relates to 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
-
公开(公告)号:US20210309734A1
公开(公告)日:2021-10-07
申请号:US17122752
申请日:2020-12-15
申请人: UCB BIOPHARMA SRL
IPC分类号: C07K16/24
摘要: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
-
公开(公告)号:US20210253688A1
公开(公告)日:2021-08-19
申请号:US17253660
申请日:2019-06-18
发明人: GARETH CHARLES GLYNDWR DAVIES , SIMON LEEDHAM , ANDREW ZANNETTINO , KIMBERLEY CLARK , DUNCAN HEWETT , VASILIOS PANAGOPOULOS
IPC分类号: C07K16/24 , A61K45/06 , G01N33/574 , C07K16/28 , A61P35/00
摘要: The invention relates to an anti-GREM1 antagonist for use in a method for the treatment or prevention of a cancer.
-
公开(公告)号:US10947304B2
公开(公告)日:2021-03-16
申请号:US16470996
申请日:2017-12-19
申请人: UCB BIOPHARMA SRL
摘要: This invention relates to crystals of the human Gremlin-1 protein, and the human Gremlin-1 protein in complex with an inhibitory antibody. The invention also relates to the structure of human Gremlin-1 (on its own, or in complex with the antibody) and uses of these structures in screening for agents which modulate Gremlin-1 activity. The invention further provides antibodies which bind an allosteric inhibitory site on Gremlin-1, together with pharmaceutical compositions and medical uses of such antibodies and agents identified by the screening methods.
-
65.
公开(公告)号:US10935553B2
公开(公告)日:2021-03-02
申请号:US15736535
申请日:2015-10-22
申请人: UCB Biopharma SRL
发明人: James Philip O'Connell , John Robert Porter , Alastair Lawson , Daniel John Lightwood , Rebecca Jayne Munro
IPC分类号: C07D401/14 , C07K14/525 , C07D471/00 , C07K14/705 , C07K16/24 , C07D213/72 , C07D235/04 , C07D239/26 , C07D471/04 , A61K47/64 , A61P37/00 , A61P35/00 , G01N33/68
摘要: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.
-
公开(公告)号:US20210005277A1
公开(公告)日:2021-01-07
申请号:US16823055
申请日:2020-03-18
申请人: UCB Biopharma SRL
摘要: Methods and associated apparatus involving designing a ligand ab initio that will bind to a binding site of a macromolecular target, or of identifying a modification to a ligand for improving the affinity of the ligand to a binding site of a macromolecular target, comprising using information about non-bonding, intra-molecular or inter-molecular atom to atom contacts extracted from a database of biological macromolecules to identify favoured regions adjacent to the binding site for particular atom types and modifying a candidate ligand to increase the intersection between atoms of the candidate ligand and the favoured regions. One or more steps of the methods may be performed by a computer.
-
公开(公告)号:US20200331960A1
公开(公告)日:2020-10-22
申请号:US16629609
申请日:2018-07-16
申请人: UCB BIOPHARMA SRL
发明人: MICHAEL HARRY ROSE
摘要: The present invention is in the field of purification and protein purification in particular. The invention provides improved techniques for the industrial-scale purification of proteins and other biomolecules. More specifically, it relates to a process for the purification of a compound of interest, such as a protein, preferably an antibody or an antibody fragment using a chromatography step, preferably a semi-continuous chromatography step.
-
公开(公告)号:US10669263B2
公开(公告)日:2020-06-02
申请号:US16349734
申请日:2017-12-08
申请人: UCB Biopharma SRL
发明人: Jag Paul Heer
IPC分类号: A61K31/506 , A61K31/4184 , C07D403/04 , A61P37/00 , A61P25/28 , A61P3/00 , A61P9/00 , A61P37/08 , A61P29/00 , A61P35/00
摘要: 2-(5-{1-[2-(Difluoromethoxy)-6-fluorobenzyl]-2-methyl-1H-benzimidazol-6-yl}pyrimidin-2-yl)propan-2-ol, or a pharmaceutically acceptable salt thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
-
公开(公告)号:US10654861B2
公开(公告)日:2020-05-19
申请号:US16086408
申请日:2017-03-31
申请人: UCB Biopharma SRL , Sanofi
发明人: Michael Louis Robert Deligny , Jag Paul Heer , Jean Keyaerts , Luce Elsa Lepissier , Martin Alexander Lowe
IPC分类号: C07D487/18 , C07D487/04
摘要: A series of substituted fused pentacyclic benzimidazole derivatives, and analogues thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
-
公开(公告)号:US20240352083A1
公开(公告)日:2024-10-24
申请号:US18647911
申请日:2024-04-26
申请人: UCB Biopharma SRL
发明人: Ralph Adams , Terence Seward Baker , Xiaofeng Liu
IPC分类号: C07K14/54 , C07K14/505 , C07K14/535 , C07K14/55 , C07K16/18 , C07K16/24 , C07K16/28
CPC分类号: C07K14/5443 , C07K14/505 , C07K14/535 , C07K14/5428 , C07K14/55 , C07K16/18 , C07K16/244 , C07K16/248 , C07K16/2809 , C07K16/2818 , C07K2317/24 , C07K2317/31 , C07K2317/55 , C07K2317/56 , C07K2317/567 , C07K2317/569 , C07K2317/622 , C07K2317/76
摘要: The present invention provides antibodies comprising a variable (V) domain and an insert polypeptide, wherein the insert polypeptide is within the framework 3 region of the V domain.
-
-
-
-
-
-
-
-
-